NC
NUVA

Nekton Capital’s NuVasive, Inc. NUVA Stock Holding History

Nekton Capital’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-53,933
Closed -$2.65M – 25
2022
Q2 		$2.65M Hold
53,933
– – 0.85% 17
2022
Q1 		$3.06M Sell
53,933
-164,533
-75% -$8.74M 0.75% 13
2021
Q4 		$11.5M Buy
+218,466
New +$11.9M 6.94% 6

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Nekton Capital's NUVA Position: Q3 2022 in Review

Nekton Capital sold out of NuVasive, Inc. (NUVA) in Q3 2022, closing a stake of 53,933 shares — an estimated $2.65M sold.

Nekton Capital first reported a position in NUVA in Q4 2021 and held it in 3 quarters. The position peaked at $11.5M in Q4 2021. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

  • Nekton Capital reported no remaining NuVasive, Inc. position as of Q3 2022 after selling out during the quarter.
  • Nekton Capital sold 53,933 NuVasive, Inc. shares in Q3 2022, an estimated $2.65M.
  • Nekton Capital first reported a position in NuVasive, Inc. in Q4 2021 and held it in 3 quarters.
  • Nekton Capital's NuVasive, Inc. position peaked at $11.5M in Q4 2021.
  • 232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on Nekton Capital's 13F filing for Q3 2022, filed 14 Nov 2022.